2022
DOI: 10.1080/09602011.2022.2157446
|View full text |Cite
|
Sign up to set email alerts
|

Methylphenidate improves cognitive function and health-related quality of life in survivors of childhood brain tumours

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
11
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(12 citation statements)
references
References 54 publications
1
11
0
Order By: Relevance
“…Despite growing evidence for the utility of psychostimulants in children with acquired brain injuries (including CNS tumors) (Hagan and Verity, 2023; Nicholls et al, 2012; Verity et al, 2022), the use of methylphenidate is not considered as a routine option in mainstream clinical practice. Respondents noted that the highly constrained resources that are available to pediatric psychologists in many pediatric neuro-oncology PTCs restricts practice to the provision of a skeleton service.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Despite growing evidence for the utility of psychostimulants in children with acquired brain injuries (including CNS tumors) (Hagan and Verity, 2023; Nicholls et al, 2012; Verity et al, 2022), the use of methylphenidate is not considered as a routine option in mainstream clinical practice. Respondents noted that the highly constrained resources that are available to pediatric psychologists in many pediatric neuro-oncology PTCs restricts practice to the provision of a skeleton service.…”
Section: Discussionmentioning
confidence: 99%
“…Held approximately twice per month, the clinic provides screening, assessment, and methylphenidate intervention, where appropriate, to survivors of childhood CNS tumors. We have found significant benefit to our patients via this intervention (Verity et al, 2022). Our clinical information sheets for parents and children, and our assessment, prescribing, and followup protocols, are available on request by any UK PTC.…”
Section: Current Survivorship Clinicmentioning
confidence: 90%
See 1 more Smart Citation
“…Evidence of the effect of longer-term use of methylphenidate in the brain tumour population is limited. Three published studies report on the effects of this treatment in cohorts at 12 months of use, two of these sourcing the same participant pool [12][13][14]. Studies of participants at 12 months showed improvement in attention as measured by the Conners' Continuous Performance Task [12] and on selective attention using the Test of Everyday Attention for Children [14].…”
Section: Introductionmentioning
confidence: 99%
“…Two studies looked at the impact of methylphenidate over a 12 month period. One of these studies was written by our team: Methylphenidate Improves Cognitive Function and Health-Related Quality of Life in Survivors of Childhood Brain Tumours [10]. We looked at anonymised data from 29 patients who were using methylphenidate.…”
mentioning
confidence: 99%